Status:
COMPLETED
Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars
Lead Sponsor:
Gihan M Abuelniel ,PhD
Collaborating Sponsors:
Cairo University
Conditions:
Carious Exposure of Pulp
Eligibility:
All Genders
7-8 years
Phase:
PHASE1
PHASE2
Brief Summary
Aim of the study: To compare the clinical and radiographic outcomes of mineral trioxide aggregate (MTA) and Biodentine as vital pulp therapy materials (pulpotomy) of cariously exposed vital immature m...
Detailed Description
Diagnosis: 1. Full history data will be collected, including personal, medical and previous dental data 2. Clinical examination using mirror and probe to assess the inclusion criteria. 3. Radiographi...
Eligibility Criteria
Inclusion
- Bilaterally Symptomatic ⁄ asymptomatic vital immature mandibular first permanent molars (with clinical carious exposure of the pulp and presence of bleeding upon exposure)
- Patients with an age range from 7-8 years.
- Absence of sinus tract, soft tissue swelling.
Exclusion
- • Molars were excluded if non-restorable.
- excessive mobility (more than 1 mm horizontally).
- Radiographic evidence of peri- and ⁄or inter-radicular lesions, internal⁄ external root resorption, pulp⁄ canal calcifications.
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03838094
Start Date
February 1 2016
End Date
September 1 2018
Last Update
February 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.